New York University Skip to Content Skip to Search Skip to Navigation Skip to Sub Navigation

Dr. Steven P. Engebretson Named Chair of NYU’s Ashman Department of Periodontology and Implant Dentistry

September 13, 2011

“I am delighted to announce that Dr. Steven P. Engebretson, a national and international authority in the areas of periodontology and implant dentistry, has been appointed the new chair of the Ashman Department of Periodontology and Implant Dentistry,” said Dr. Charles Bertolami, Dean, New York University College of Dentistry.  “Dr. Engebretson will formally assume his duties on October 1, 2011. He succeeds Dr. Stuart M. Hirsch, who has done an outstanding job as interim chair of the department,” Bretolami said.

Dr. Engebretson comes to NYUCD from the School of Dental Medicine at Stony Brook University, where he has served as associate professor of periodontology and implant dentistry since 2008. An expert in the area of diabetes and oral health, Dr. Engebretson received a $12.5 M grant from the NIH in 2008 for a major diabetes and periodontics clinical trial: The Diabetes and Periodontal Therapy Trial (DPTT). Dr Engebretson will remain the Study Chair and Principal Investigator of this award, which is scheduled to be completed in 2013. He is also the principal investigator on three supplemental awards for the DPTT totaling more than $2.5 M. Dr. Engebretson earned his dental degree at Harvard University after receiving a BA from New York University.  He also holds an MS degree in periodontics from Columbia University and an MS degree in biostatistics focusing on patient-oriented research from the Mailman School of Public Health at Columbia University.

Dr. Engebretson is an associate editor of the Journal of Periodontology and maintains a private practice limited to periodontics and implant dentistry. He was awarded a US patent for “Methods for Facilitating Metabolic Control,” and has several additional patents pending. He is the founder of KT Therapeutics, LLC, and OraDelivery, LLC,  privately-held biotechnology companies, and is a prolific author and lecturer.

“With his strong academic background and entrepreneurial orientation, Dr. Engebretson brings immense distinction and potential for future achievements to his new post. I hope that you will make him feel especially welcome when he joins us on October 1,” said Bertolami.

Type: Article

Press Contact: Christopher James | (212) 998-6876

Dr. Steven P. Engebretson Named Chair of NYU’s Ashman Department of Periodontology and Implant Dentistry

Dr. Steven P. Engebretson


Search News



NYU In the News

Entrepreneurship Lab Opens at NYU

Crain’s New York Business covered the opening of the Mark and Debra Leslie Entrepreneurial eLab, which will be the headquarters for NYU’s Entrepreneurial Institute and all of the University’s programs aimed at promoting innovation and startups.

A Globalizer for N.Y.U. in Abu Dhabi

The New York Times profiled Bill Bragin who will become the first executive artistic director of NYU Abu Dhabi’s new performing arts center.

Think Tank to Ponder a Future for Ballet

The New York Times profiled Jennifer Homans, the director of NYU’s new Center for Ballet and the Arts.

The Brilliant Ten: Jonathan Viventi Builds Devices That Decode Thoughts

Popular Science named Assistant Bioengineering Professor Jonathan Viventi as one of its “brilliant ten” for his research into brain implants that could one day halt epileptic episodes:

Living and Leaving the Dream: Adrian Cardenas’ Journey from the Major Leagues to College

The New York Times ran a feature on Adrian Cardenas, a former major league baseball player who is now studying philosophy and creating writing at NYU.

NYU Footer